Background: Children and adolescents are being treated increasingly for attention-
deficit/hyperactivity disorder (ADHD) with a variety of stimulants in higher than Food and …

This was a 1-month, multicenter, open-label, randomized study to determine single-and
multiple-dose pharmacokinetics of d, l-methylphenidate (MPH) after MPH transdermal …

Objectives: The purpose of this study was to identify the optimal dose of osmotic release oral
system methylphenidate (OROS-MPH) using a dosage forced-titration scheme to achieve …

Objective: The aim of this study was to compare efficacy and safety of two long-acting
formulations of methylphenidate (MPH) for attention-deficit/hyperactivity disorder (ADHD) in …

Objective This was a single-dose, one-period, multicenter, pharmacokinetic (PK) study to
evaluate the PK of methylphenidate (MPH) hydrochloride multilayer extended-release …

This study examined the efficacy and safety of osmotic release oral system methylphenidate
(OROS MPH) as compared with immediate-release MPH (IR MPH) in children with attention …

Background Despite the persistence of attention-deficit/hyperactivity disorder (ADHD) into
adolescence, little is known about the efficacy and tolerability of stimulant medications in this …

Objective: Psychostimulants are effective treatments for attention-deficit/hyperactivity
disorder (ADHD) but may be associated with euphoric effects, misuse/diversion, and …

Objective: The aim of this study was to compare the pharmacokinetics of immediate-release
methylphenidate (MPH) in preschool and school-aged children with attention …

Objective: To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …